CapsoVision, Inc

8-K · cv-20260611.htm iXBRL

0001378325 2026-06-11 2026-06-11

 UNITED STATES
 SECURITIES AND EXCHANGE COMMISSION
 Washington, D.C. 20549
 _________________________
 FORM 8-K
 _________________________
 CURRENT REPORT
 Pursuant to Section 13 or 15(d)
 of the Securities Exchange Act of 1934
 Date of Report (Date of earliest event reported): June 11, 2026
 _________________________
 CapsoVision, Inc.
 (Exact name of registrant as specified in its charter)
 _________________________

 Delaware 001-42705 20-3369494
 (State or other jurisdiction
of incorporation) (Commission
File Number) (IRS Employer
Identification Number)

 18805 Cox Avenue , Suite 250
 Saratoga , California
 95070
 (Address of Principal Executive Offices) (Zip Code)

 Registrant’s telephone number, including area code: (408) - 624-1488
 n/a
 (Former Name or Former Address, if Changed Since Last Report)
 _________________________
 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 Securities registered pursuant to Section 12(b) of the Act:

 Title of each class Trading
Symbol Name of each exchange
on which registered
 common stock, $0.001 par value per share CV The Nasdaq Stock Market LLC

 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 Emerging growth company  ☒
 If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 Item 5.07.           Submission of Matters to a Vote of Security Holders.

 The 2026 Annual Meeting of Stockholders (the "Meeting") of CapsoVision Inc (the "Company") was held on June 11, 2026. At the Meeting, the Company's stockholders voted on the following two proposals, each of which is disclosed in more detail in the Proxy Statement filed on April 28, 2026. The stockholders cast their votes as described below.

 1. Proposal #1 for the election (re-election) of the Class I Directors. The nominees listed below were re-elected at the Meeting to serve as Class I Directors of the Company until the Company's 2029 annual meeting of stockholders.

 Nominee For Withheld Broker Non-Votes
 Joanne Imperial, M.D. 32,060,734 70,447 2,244,596
 Wen-Herng (Henry) King 32,065,119 66,062 2,244,596
 Michele Harari 32,066,645 64,536 2,244,596

 2. Proposal #2 for the ratification of the appointment of Baker Tilly US, LLP as the Company's independent registered public accounting firm for the 2026 fiscal year was approved.

 For Against Abstained Broker Non-Votes
 34,321,524 154 54,099 N/A

 SIGNATURES
 Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 CAPSOVISION, INC.

 Date: June 12, 2026 By: /s/ Kang-Huai (Johnny) Wang
 Name: Kang-Huai (Johnny) Wang
 Title President and Chief Executive Officer